Huang, Jieping
Hou, Xuejiao
Li, Moyan
Xue, Yingshuang
An, Jiangfei
Wen, Shenglin
Wang, Zi
Cheng, Minfeng
Yue, Jihui
Article History
Received: 13 June 2023
Accepted: 19 September 2023
First Online: 16 October 2023
Declarations
:
: The authors declare no competing interests.
: Not applicable.
: The research was conducted according to the International Conference on Harmonization – Good Clinical Practice Guidelines and the Declaration of Helsinki. The study procedures were reviewed and approved by the Medical Ethic Committee Review Board of the Fifth Affiliated Hospital of Sun Yat-sen University (Approval number: [2022] K44-1). The need for informed consent was waived by the Medical Ethic Committee Review Board of the Fifth Affiliated Hospital of Sun Yat-sen University. This was because the research used human materials or data with identifiable personal information, but the subject could no longer be found and the research project did not involve personal privacy or commercial interests, according to the Article 39 of the ‘Ethical Review Measures for Biomedical Research Involving Humans’ issued by the National Health and Family Planning Commission of the People’s Republic of China.